期刊文献+

递呈乳腺癌细胞MCF-7肿瘤抗原的树突状细胞对T细胞的激活 被引量:2

T lymphocytes activation by dentritic cells loaded with the tumor antigen from breast cancer cells MCF-7
下载PDF
导出
摘要 目的:在体外利用细胞因子的诱导获取树突状细胞(DC),并观察递呈肿瘤抗原后的成熟DC对T细胞的激活作用。方法:健康人外周血单个核细胞(PBMC)在体外用细胞因子诱导获取DC,并经乳腺癌细胞MCF-7肿瘤细胞裂解物体外冲击,再以1∶5的比例将致敏DC与T细胞共同孵育5d并共同作为效应细胞,通过FACS分析T细胞激活前后的表型变化以及MTT试验观察体外特异性肿瘤杀伤效果。结果:DC在细胞因子的诱导下7d后,形态学表现为伸出许多伪足样突起,在摄取抗原后可见内吞样小泡。FACS检测呈现成熟DC的标志,CD40、CD83、CD80、CD86和HLA-DR等高表达。另外,未经成熟DC激活的T淋巴细胞以辅助性T细胞(Th)为主,CD4+52.1%,CD8+仅22.1%;而经成熟DC激活的T淋巴细胞以杀伤性T细胞(Tc)为主,CD4+32.6%,CD8+64.2%。同时,MTT试验证实经递呈MCF-7肿瘤抗原的DC激活了细胞毒性T淋巴细胞(CTL),并对MCF-7具有特异性肿瘤杀伤作用。结论:体外递呈肿瘤抗原MCF-7的成熟DC对T细胞具有激活作用,并产生肿瘤特异性CTL。 OBJECTIVE:To explore T lymphocytes acti-vation by dentritic cells (DCs)induced by several kinds of cyto-kine and loaded with the tumor antigen. METHODS: DCs de-rived from the heathy donor's peripheral blood monocyte(PB-MC) were isolated and induced by the cytokine in vitro, and then were pulsed with lysates from breast cancer cells MCF-7.The DCs were co-incubated with T cells(DC : T cell = 1 : 5)for 5 days. T cells were analysed by fluorescence-activated cell sorter(FACS). MTT assay was used to estimate specific cyto-toxic activity to MCF-7. RESULTS:The mature DCs sticked out many pseudopods on the 7th day . Some endosomal vesiclescould be seen after tumor antigen was captured. By FACS a-nalysis, the mature DCs' surface marker were upregulated compared with immature DCs, including CD40, CD83, CDS0, CD86 and HLA-DR. T cells were composed of 52.1% CD4^+ and 22.1% CD8^+. However, T cell induced by tumor cell-loaded DC consisted of 32.6% CD4^+ and 64.2% CD8^+ . MTT assay revealed that the cytokine-driven DCs pulsed with whole tumor lystate induced a strong specific CTL cytotoxicity to MCF-7. CONCLUSION: In vitro T lymphocytes can be activa-ted by the mature DCs loaded with the tumor antigen and pro-duce the activation of tumor-specific CTL against target cells.
出处 《中华肿瘤防治杂志》 CAS 2007年第17期1288-1291,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 天津市科委重大攻关项目(023111511-8)
关键词 乳腺肿瘤 病理学 树突细胞 T淋巴细胞 细胞毒性 细胞因子类 肿瘤细胞 培养的 breast neoplasms pathology dendritic cells T-lymphocytes,cytotoxic cytokines tumor cells, cultured
  • 相关文献

参考文献10

  • 1den-Brok M H,Nierkens S,Figdor C G,et al.Dendritic cells:tools and targets for antitumor vaccination[J].Expert Rev Vaccines,2005,4(5):699-710.
  • 2Usharauli D.Dendritic cells and the immunity/tolerance decision[J].Med Hypotheses,2005,64(1):112-113.
  • 3沈关心,周汝鳞.现代免疫学实验技术[M].2版.武汉:湖北科学技术出版社,2002:377-389.
  • 4郭建巍,蔡美英,秦力维,董薇,魏大鹏.树突状细胞负载肝癌可溶性抗原后的免疫应答[J].免疫学杂志,2002,18(2):123-127. 被引量:11
  • 5Cuellar A,Fonseca A,Gomez A,et al.Effect of lipopolysaccharides on human dendritic cell cultures and its inhibition by polymyxin B[J].Biomedica,2004,24(4):413-422.
  • 6Grauer O,Wohlleben G,Seubert S,et al.Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique[J].Histochem Cell Biol,2002,117(4):351-362.
  • 7Aalamian M,Tourkova I L,Chatta G S,et al.Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen[J].J Urol,2003,170(5):2026-2030.
  • 8席泓,古涛,朱一蓓,戚春建,顾宗江,束永前,张学光.凋亡肿瘤细胞负载的树突状细胞对抗原特异性CTL的激活[J].上海免疫学杂志,2002,22(5):297-300. 被引量:6
  • 9Rouard H,Leon A,de-Reys S,et al.A closed and single-use system for monocyte enrichment:potential for dendritic cell generation for clinical applications[J].Transfusion,2003,43(4):481-487.
  • 10McMahan R H,McWilliams J A,Jordan K R,et al.Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines[J].J Clin Invest,2006,116(9):2543-2551.

二级参考文献13

  • 1[1]Banchereau J,Steinman R. Dendritic cells and the control of immunity [J]. Nature, 1998,392:245
  • 2[2]Berard F, Blanco P, Davoust J, et al. Cross-priming of naive CD8 + T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells[J]. J Exp Med,2000,192:1535
  • 3[3]Nouri-Shirazi M,Benchereau J,Bell D,et al. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific im mune response[ J]. J Immunol, 2000,165: 3797
  • 4[4]Holmes LM,Li J,Robert P,et al. A rapid,novel strategy to induce tu mor cell-specific cytotoxic T lymphocyte responses using instant den dritomas[ J]. J Immunol,2001,24:122
  • 5[5]Bennett SRM,Carbone FR,Karamalis F,et al. Help for the cytotoxic T-cell responses is mediated by CD40 signaling [ J]. Nature, 1998, 393:478
  • 6[6]Schoenburger S, Toes REM, van de Voort EIH, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions[ J]. Nature, 1998,393:480
  • 7[7]Zhou ZH, Wang JF, Wang YD, et al. An agonist anti-human CD40 monoclonal antibody that induce dendritic cell formation and mature in hibits proliferation of myeloma cell line [ J ]. Hybridoma, 1999,18: 471
  • 8[8]Zhang XG,Klein B,Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma[J]. Blood, 1989,74:11
  • 9[9]Kelleher M,Beverley PCL. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTL from naive polyclonal CD8+ T cells in vivo, whereas CD40 ligation is essential [J]. J Immunol,2001,167:6247
  • 10杨连君,隋延仿,陈志南,徐力青,米力,刘智广.肝癌细胞表面HLA-DR抗原的初步研究[J].第四军医大学学报,1997,18(6):581-581. 被引量:2

共引文献26

同被引文献18

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部